Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14082-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14082-1-AP, RRID:AB_2157296
- Product name
- OVOL1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated OVOL1 antibody (Cat. #14082-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Dual activation of AhR and Nrf2 pathways by the natural stilbenoid tapinarof protects against particulate matter-induced skin barrier dysfunction.
Transplacental transfer of metformin and interaction of metformin with the uptake transporters of placental trophoblast cells.
Unveiling the impact of OVOL1 on prognosis, immune microenvironment, and proliferation in pancreatic cancer.
Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse.
Skin colonization by Staphylococcus aureus in hemodialysis patients with pruritus and the effect of Staphylococcus aureus-secreted α-toxin on filaggrin expression.
Twist1 is required for the development of UVB-induced squamous cell carcinoma.
αvβ3 Integrin induces partial EMT independent of TGF-β signaling.
HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer.
Lin CH, Ko HH, Wu JY, Chang HS, Yen CH, Chiu CC, Chen YF
Toxicology and applied pharmacology 2025 Sep 11;505:117559
Toxicology and applied pharmacology 2025 Sep 11;505:117559
Transplacental transfer of metformin and interaction of metformin with the uptake transporters of placental trophoblast cells.
Gu X, Cai Y, Zheng C, Li K, Zhu S, Zhang S, Wang Z, Xiang J, Cheng Z, Ai X, Yang C
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2025 Sep 1;212:107161
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2025 Sep 1;212:107161
Unveiling the impact of OVOL1 on prognosis, immune microenvironment, and proliferation in pancreatic cancer.
Li J, Deng Z, Yan Z, Huang S, Jin J, Xie C, Gan J
Scientific reports 2025 Jul 28;15(1):27417
Scientific reports 2025 Jul 28;15(1):27417
Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse.
Drago-Garcia D, Giri S, Chatterjee R, Simoni-Nieves A, Abedrabbo M, Genna A, Rios MLU, Lindzen M, Sekar A, Gupta N, Aharoni N, Bhandari T, Mayalagu A, Schwarzmüller L, Tarade N, Zhu R, Mohan-Raju HR, Karatekin F, Roncato F, Eyal-Lubling Y, Keidar T, Nof Y, Belugali Nataraj N, Bernshtein KS, Wagner B, Nair NU, Sanghvi N, Alon R, Seger R, Pikarsky E, Donzelli S, Blandino G, Wiemann S, Lev S, Prywes R, Barkan D, Rueda OM, Caldas C, Ruppin E, Shiloh Y, Dahlhoff M, Yarden Y
Science signaling 2025 Apr 22;18(883):eado3473
Science signaling 2025 Apr 22;18(883):eado3473
Skin colonization by Staphylococcus aureus in hemodialysis patients with pruritus and the effect of Staphylococcus aureus-secreted α-toxin on filaggrin expression.
Tsai YY, Chen YJ, Chang LS, Wu CC
The Journal of dermatology 2024 Oct;51(10):1318-1328
The Journal of dermatology 2024 Oct;51(10):1318-1328
Twist1 is required for the development of UVB-induced squamous cell carcinoma.
Eguiarte-Solomon F, Blazanin N, Rho O, Carbajal S, Felsher DW, Tran PT, DiGiovanni J
Molecular carcinogenesis 2021 May;60(5):342-353
Molecular carcinogenesis 2021 May;60(5):342-353
αvβ3 Integrin induces partial EMT independent of TGF-β signaling.
Kariya Y, Oyama M, Suzuki T, Kariya Y
Communications biology 2021 Apr 21;4(1):490
Communications biology 2021 Apr 21;4(1):490
HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
Chen L, Guo P, He Y, Chen Z, Chen L, Luo Y, Qi L, Liu Y, Wu Q, Cui Y, Fang F, Zhang X, Song T, Guo H
Cell death & disease 2018 May 1;9(5):513
Cell death & disease 2018 May 1;9(5):513
cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.
Chen L, Fu H, Luo Y, Chen L, Cheng R, Zhang N, Guo H
Cell death & disease 2017 Apr 6;8(4):e2728
Cell death & disease 2017 Apr 6;8(4):e2728
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer.
Roca H, Hernandez J, Weidner S, McEachin RC, Fuller D, Sud S, Schumann T, Wilkinson JE, Zaslavsky A, Li H, Maher CA, Daignault-Newton S, Healy PN, Pienta KJ
PloS one 2013;8(10):e76773
PloS one 2013;8(10):e76773
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The OVOL1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human OVOL1. This antibody recognizes human, mouse, rat antigen. The OVOL1 antibody has been validated for the following applications: ELISA, WB analysis.
